Utilization of voriconazole drug monitoring in the treatment of cutaneous Scedosporium apiospermum infection

被引：6

作者：

Boyd, McKenna E. ^{[1
]}

Dao, Harry ^{[2
]}

Estep, Jerry D. ^{[3
]}

Huttenbach, Yve T. ^{[4
]}

Hemmige, Vagish ^{[5
]}

机构：

[1] Baylor Coll Med, 1 Baylor Plaza, Houston, TX 77030 USA

[2] Baylor Coll Med, Dept Dermatol, 1977 Butler Blvd, Houston, TX 77030 USA

[3] Cleveland Clin, Dept Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA

[4] Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA

[5] Montefiore Med Ctr, Dept Infect Dis, 111 East 210th St, Bronx, NY 10467 USA

来源：

MEDICAL MYCOLOGY CASE REPORTS | 2018年 / 22卷

关键词：

Cutaneous Scedosporium apiospermum; Voriconazole; Trough; Transplant; Immunocompromised;

D O I：

10.1016/j.mmcr.2018.09.002

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

We report the use of voriconazole troughs to achieve appropriate therapeutic levels in treatment of a cutaneous Scedosporium apiospermum infection. Following heart transplantation, a 63-year-old immunocompromised patient presented with post-traumatic nodular lesions on his right shin. Pathology showed fungal yeasts with culture revealing Scedosporium apiospermum. According to therapeutic drug monitoring, initial voriconazole treatment was subtherapeutic requiring increased dosing until appropriate therapeutic trough levels were attained, and resolution of the fungal infection was achieved.

引用

页码：52 / 54

页数：3

共 50 条

[21] Successful treatment of chronic meningitis caused by Scedosporium apiospermum with oral voriconazole
Danaher, PJ
Walter, EA
[J]. MAYO CLINIC PROCEEDINGS, 2004, 79 (05) : 707 - 708
[22] Cutaneous Scedosporium apiospermum infection in an immunocompromised patient and a review of the literature
Uenotsuchi, T
Moroi, Y
Urabe, K
Tsuji, G
Koga, T
Matsuda, T
Furue, M
[J]. ACTA DERMATO-VENEREOLOGICA, 2005, 85 (02) : 156 - 159
[23] Activity of voriconazole against corneal isolates of Scedosporium apiospermum
Shah, KB
Wu, TG
Wilhelmus, KR
Jones, DB
[J]. CORNEA, 2003, 22 (01) : 33 - 36
[24] Scedosporium apiospermum traumatic endophthalmitis successfully treated with voriconazole
Zarkovic A.
Guest S.
[J]. International Ophthalmology, 2007, 27 (6) : 391 - 394
[25] Scedosporium apiospermum fungemia successfully treated with voriconazole and terbinafine
Jabr, Ra'ed
Hammoud, Kassem
[J]. IDCASES, 2020, 22
[26] Endogenous endophthalmitis caused by Scedosporium apiospermum treated with voriconazole
Figueroa, MS
Fortun, J
Clement, A
De Arévalo, BF
[J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2004, 24 (02): : 319 - 320
[27] A Case of Localized Cutaneous Infection Caused by Scedosporium apiospermum Presenting as Cellulitis
Noh, Soo Hyeon
Na, Ga Hye
Park, Kun
Kim, Eun Jung
[J]. ANNALS OF DERMATOLOGY, 2017, 29 (05) : 640 - 642
[28] Mycophenolic acid/prednisone/tacrolimusDisseminated cutaneous zoster infection and cutaneous Scedosporium apiospermum infection: case report
[J]. Reactions Weekly, 2018, 1724 (1) : 271 - 271
[29] Successful Salvage Treatment of Scedosporium apiospermum Keratitis with Topical Voriconazole After Failure of Natamycin
Al-Badriyeh, Daoud
Leung, Lok
Davies, Geoffrey E.
Stewart, Kay
Kong, David
[J]. ANNALS OF PHARMACOTHERAPY, 2009, 43 (06) : 1139 - 1142
[30] Disseminated Scedosporium Apiospermum infection in renal transplant recipient:: Long-term successful treatment with voriconazole:: A case report
Rogasi, P. G.
Zanazzi, M.
Nocentini, J.
Fantoni, E.
Trotta, M.
Faggi, E.
Fontanelli, A.
Bertoni, E.
Salvadori, M.
Leoncini, F.
[J]. TRANSPLANTATION PROCEEDINGS, 2007, 39 (06) : 2033 - 2035

← 1 2 3 4 5 →